Viridian Therapeutics (VRDN) was a big mover in the most recent session on higher-than-average trading volume. However, a trend of earnings estimate revisions is signaling potential headwinds and may limit the stock's ability to continue moving higher in the near term.
Viridian Therapeutics (VRDN) was a big mover in the most recent session on higher-than-average trading volume. However, a trend of earnings estimate revisions is signaling potential headwinds and may limit the stock's ability to continue moving higher in the near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly negative
Sentiment Score
-0.20
Ticker Sentiment
